Mike Kope

Prior to BioMarker, Mr. Kope was Director of Corporate Development for MedImmune, Inc., serving the MedImmune Vaccines unit formerly known as Aviron. He came to Aviron a few years after having licensed the company its core FluMist™ technology from the University of Michigan, where he served as the University's Intellectual Property Counsel.

Mr. Kope has negotiated a broad range of business acquisition and partnership agreements, designed strategies for technology protection and promotion in many fields of research, and facilitated a number of successful university spin-offs. He received his JD from the University of Michigan in 1990.